Australia's Vitrafy Life Sciences flat; Bell Potter raises PT on cash flows hopes

Vitrafy Life Sciences

06/08/2025 04:26

** Vitrafy Life Sciences VFY.AX trading flat at A$1.6

** Bell Potter raises PT  by 10 Au cents to A$2.10; retains "speculative buy"

** Expects higher cash flows on visibility of commercial launch timing of its VCU2 cryopreservation device in FY26

** Views recent leadership changes positively

** Ord Minnett assigns "speculative buy", with PT of A$2.30, per data compiled by LSEG

 (Reporting by Nichiket Sunil in Bengaluru)

 ((Nichiket.Sunil@thomsonreuters.com))